Vanberra Signal

Mirvie

Curated by Signal

Provider of non-invasive diagnostic tests for pregnant women

Overview

Provider of non-invasive diagnostic tests for pregnant women. The company offers blood test-based diagnostics to predict the fetal development and health conditions of prenatal babies. They perform the detection of nine cell-free RNA (cfRNA) which help in measuring the gestational age of the fetal. The other non-invasive tests in which the maternal blood is analyzed for the cRNA to detect the preterm risk management solutions(advance of labor) in women.

Key facts

Founded
2018

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of non-invasive cardiac imaging and monitoring devices

    Life Sciences TechnologySomerville, United States
  • Range of sleep testing devices and services

    Life Sciences TechnologyCleveland, United States
  • Provider of cloud-based remote telemonitoring platform for healthcare providers

    Life Sciences TechnologyValley City, United States

About Mirvie

What does Mirvie do?

Provider of non-invasive diagnostic tests for pregnant women.

Where is Mirvie headquartered?

Mirvie is headquartered in San Francisco, United States.

When was Mirvie founded?

Mirvie was founded in 2018.

Which sector is Mirvie in?

Mirvie operates in Life Sciences Technology.

Who are Mirvie's competitors?

Companies similar to Mirvie include Cauchy Analytics, CleveMed, and Preventice Solutions.